Is Kratom Legal in Hawaii? State Law and Shipping Guide

What Hawaii law says about kratom

Hawaii's current statewide legal position begins with the laws that are actually in force. The controlled-substance schedules in chapter 329 of the Hawaii Revised Statutes identify the substances placed in Schedules I through V. Traditional kratom, the plant Mitragyna speciosa, mitragynine, and 7-hydroxymitragynine are not named in those current statutory schedules. Hawaii therefore does not treat ordinary kratom leaf as a scheduled controlled substance at the statewide level.

That does not mean every item sold under a kratom-related name has the same legal or regulatory footing. General Hawaii food, drug, labeling, and consumer-protection requirements continue to apply according to the character and marketing of a finished product. A botanical powder, a capsule filled with leaf material, a concentrated extract, and a product containing a synthesized alkaloid may present different compliance questions even when their packaging uses similar terminology.

The clearest current agency statement concerns 7-hydroxymitragynine, commonly shortened to 7-OH. On May 11, 2026, the Hawaii Department of Health warned about concentrated and, in some cases, synthetic 7-OH products. The department described those products as distinct from traditional kratom leaf and identified gummies, tablets, drink shots, and flavored preparations among the formats appearing in commerce. The advisory also relayed the federal Food and Drug Administration's position that products with added 7-OH are not lawful dietary supplements and cannot legally be added to foods.

An agency advisory is not the same thing as a Hawaii statute placing traditional kratom in a controlled-substance schedule. It is nevertheless relevant to product selection because it shows the state health department's current enforcement and public-health focus. Kratom Paradise does not treat concentrated 7-OH products as interchangeable with ordinary leaf, capsules, or conventional botanical extracts.

Hawaii has also considered legislation that would create a much more detailed regulated market. Senate Bill 463 and its House companion, House Bill 717, proposed registration, testing, labeling, product-composition, format, and age requirements. The official measure page shows that SB 463 was carried over to the 2026 regular session but does not list an act number. Its latest substantive committee actions remain deferrals from February 2025. Those proposed requirements therefore should not be presented as current Hawaii law.

The difference between an introduced bill and an enacted statute is especially important here. The bill text contains specific concepts such as a two-percent limit for 7-hydroxymitragynine within the alkaloid fraction, restrictions on synthesized materials, registration with the Department of Health, laboratory certificates, detailed warnings, and an under-18 sales rule. None of those proposed kratom-specific provisions became operative merely because the bill described a January 1, 2026 effective date. A proposed effective date has legal force only if the measure completes the legislative process and becomes law.

How Hawaii's statewide position developed

• 2020SB 3064 proposed placing mitragynine and 7-hydroxymitragynine in Schedule V, but the proposal did not become part of Hawaii's current controlled-substance schedules.
• 2022SB 3307 proposed a consumer-protection framework addressing adulteration, synthetic alkaloids, labels, and sales to people under 18. It was not enacted.
• 2024SB 3372 again proposed a Hawaii Kratom Consumer Protection Act with product and labeling standards. It did not become current law.
• January 16, 2025SB 463 was introduced with a proposed registration and consumer-protection system.
• February 12, 2025The Senate Commerce and Consumer Protection and Health and Human Services committees deferred SB 463.
• December 8, 2025The official measure record marked SB 463 as carried over to the 2026 regular session.
• May 11, 2026The Hawaii Department of Health issued its statewide warning focused on concentrated and synthetic 7-OH products.
• July 21, 2026No act number appears for SB 463, and traditional kratom remains outside Hawaii's named controlled-substance schedules.

This history shows sustained legislative interest without a completed kratom-specific enactment. Several proposals have shared themes: keeping traditional botanical material separate from synthesized compounds, limiting elevated 7-OH, requiring clear package information, and setting a minimum age. Those themes help explain the direction of policy debate, but the current statewide answer remains anchored to enacted statutes and the official status of each proposal.

The May 2026 health advisory is the most recent official statewide development. It does not announce a ban on ordinary kratom leaf. Instead, it warns that concentrated 7-OH and synthetic kratom-derived products are materially different from traditional leaf products. Consumers comparing packages should therefore look beyond the word kratom and identify the actual ingredient, concentration, and format being offered.

Powder, capsules, extracts, tablets, and other formats

Hawaii's lack of a kratom-specific consumer statute does not make product identity irrelevant. Traditional leaf powder and capsules containing that powder are the clearest examples of botanical kratom. They retain the plant's naturally occurring mixture of constituents rather than presenting a single isolated or synthesized compound as the entire product.

• Leaf powder: traditional ground Mitragyna speciosa leaf remains available at the statewide level.
• Powder-filled capsules: ordinary capsules are another delivery format for leaf material and are not separately scheduled by Hawaii law.
• Botanical extracts: extracts vary significantly in concentration and composition, so the ingredient statement and supporting analysis matter more than the word extract alone.
• MIT-labeled formats: a product identified by mitragynine strength should be evaluated according to its actual composition and whether it remains a botanical extract rather than a synthesized derivative.
• 7-OH products: Hawaii's May 2026 advisory specifically focuses on concentrated and synthetic 7-hydroxymitragynine products and distinguishes them from traditional leaf.
• Gummies, shots, and flavored products: these forms receive particular attention in the advisory when used to deliver added or highly concentrated 7-OH.

For ordinary powder and capsules, useful package information includes the plant identity, net quantity, ingredient list, business identity, lot or batch reference, and storage directions. For extracts, a certificate of analysis can also help distinguish a conventional botanical extract from an item built around added or synthesized alkaloids. Those practices support accurate commerce even where the state has not imposed a dedicated kratom-label statute.

The pending SB 463 language is also useful for understanding why format distinctions may remain prominent in future Hawaii policy. The proposal would prohibit combustible, vaporized, injectable, child-attractive, adulterated, and certain synthesized products while creating a registration pathway for qualifying edible forms. Because the measure is not enacted, those details are legislative proposals rather than current kratom-specific requirements. They should be monitored rather than prematurely applied as law.

Kratom shipping to Hawaii from Las Vegas

Kratom Paradise currently accepts eligible Hawaii orders for traditional leaf powder, capsules, and qualifying botanical formats. The regional shipping display is approximately one business day after carrier acceptance. That timing is an estimate rather than a guarantee; air transportation, island routing, weekends, holidays, weather, address corrections, and carrier operations can extend delivery.

Hawaii has no enacted kratom-specific statewide minimum age in the current statutes reviewed for this update. Kratom Paradise may still apply its own responsible adult-ordering standards and product eligibility controls. Store policy does not convert a pending bill's proposed age rule into state law, and the legal summary should keep that distinction clear.

Orders are screened by product identity as well as destination. Traditional botanical products are not grouped with concentrated or synthetic 7-OH products simply because both may be marketed with kratom terminology. The May 2026 Department of Health advisory makes that distinction especially relevant for Hawaii shipments.

The pending registration system in SB 463 is not currently an operative prerequisite for shipping traditional kratom to Hawaii. If Hawaii later enacts registration, testing, age-verification, or package requirements, shipping eligibility will need to be reassessed against the final act and any implementing rules. Until then, the official measure status and current statutory schedules support statewide availability for eligible traditional kratom products.

Official Hawaii sources reviewed

• Hawaii Legislature: SB 463 measure status
  The current official history showing committee deferrals, carryover to 2026, and no act number.
• Hawaii Legislature: text of SB 463
  The proposed, but not enacted, Hawaii Kratom Consumer Protection Act.
• Hawaii Department of Health: May 2026 7-OH advisory
  The state's current advisory distinguishing concentrated and synthetic 7-OH products from traditional kratom leaf.
• Hawaii Revised Statutes § 329-14
  Hawaii's current Schedule I controlled-substance list.
• Hawaii Revised Statutes § 329-22
  Hawaii's current Schedule V controlled-substance list.
• Hawaii Legislature: SB 3372
  An earlier consumer-protection proposal that did not become current law.

Last reviewed: Verified July 21, 2026. Statewide information only; not legal advice.